Saxenhammer & Co. advises Teccom Pharma on its sale to Regional Investors
Saxenhammer & Co. acted as the exclusive sell-side advisor to Teccom Pharma on its sale to Regional Investors. Sarstedt-based Teccom Pharma GmbH is specialised in pharmaceutical wholesale and intermediate trading. The range of services offered extends from wholesale and intermediary trade of pharmaceutical prescription (Rx), over-the- counter (OTC) products to logistics services and marketing tailored to the pharmaceutical sector. The company had to file for insolvency proceedings with the local court, mainly caused by the outbreak of the Covid-19 pandemic, which triggered a downward spiral of falling sales revenues and a resulting liquidity bottleneck. Saxenhammer & Co. was mandated as the exclusive M&A advisor. A broad investor search across Europe has been initiated to identify an investor that would takeover the company. The investors’ interest in the company grew due to its excellent access to the pharmaceutical ecosystem with high profile customers across Germany. Teccom Pharma has been acquired by two regional investors based in Lower Saxony, both focusing on trading with pharmaceutical and healthcare products, in particular Rx and OTC (prescription and non-prescription) drugs. With the acquisition of parts of Teccom Pharmas assets, the acquirer will strengthen its sales network in the pharmaceutical space and expand its wholesale capabilities. The Saxenhammer & Co. deal team was led by Carina Küffen (Director) who was supported by Pattman Hemat (Analyst).
Saxenhammer is regularly featured in media outlets and publishes sector updates.